logo
NEWS & MEDIA / GENETIC HEALTH TESTING FOR APPALOOSA HORSES

Genetic Health Testing for Appaloosa Horses

June 20, 2024

Like any breed, Appaloosa horses, known for their eye-catching spotted coats and versatility, can be predisposed to certain genetic health conditions. While they are typically a fairly hardy breed, Appaloosas may face some genetically linked health conditions more frequently than others. This includes:

An Appaloosa horse is shown standing with call-outs about genetic health risks that are common in Appaloosa horses and can be DNA tested for with Etalon Equine Genetics.

Hyperkalemic Periodic Paralysis (HYPP)

While HYPP is most commonly associated with Quarter Horses, some Appaloosas may also carry the gene mutation responsible for this condition due to their shared ancestry. HYPP causes episodes of muscle tremors, weakness, and paralysis due to abnormal sodium channels in muscle cells. Heterozygous horses (HYPP/n) experience more moderate symptoms that can usually be managed through diet and exercise. Homozygous horses (HYPP/HYPP) are much more severely affected, and some breed registries will not accept these animals. Genetic testing is the only way to know for sure if your Appaloosa has HYPP.

Congenital Stationary Night Blindness (CSNB)

CSNB is a recessive disorder caused by Leopard Complex Spotting (LP), also known as Appaloosa spotting. This genetic condition, which occurs when a horse is homozygous for LP (LP/LP), affects the horse's vision, particularly in low-light conditions. Appaloosas with CSNB may have difficulty seeing in dim light or at night. While they can still get along well during the day, their vision may be impaired in certain lighting conditions. Observable coat pattern alone is not necessarily enough to identify CSNB-affected horses, especially those who have minimal patterning, which is why genetic testing is highly recommended to verify a horse’s LP genotype.

Equine Metabolic Syndrome / Laminitis Risk (EMS / LAM)

EMS is a metabolic disorder that can affect horses of any breed, including Appaloosas. EMS is characterized by insulin dysregulation, obesity, and an increased risk of laminitis. Researchers studied horses with severe laminitis caused by EMS and discovered important genetic markers near a gene that might affect how the horses manage cholesterol. Horses with these genetic markers, both hetero- (EMS/n) and homozygous (EMS/EMS), were 9x more likely to develop laminitis secondary to EMS, especially if they were also overweight or obese. This is a genetic health risk, meaning if your horse carries one or two copies of the variant, they are not necessarily destined to develop the disease but it does indicate that they are at a higher risk of developing it.

Equine Recurrent Uveitis Risk and Severity (ERUR / ERUS)

Also known as moon blindness, ERU is a common cause of blindness in horses, including Appaloosas. It is an inflammatory condition that affects the uveal tract of the eye. Symptoms include tearing, squinting, sensitivity to light, and cloudiness of the eye(s). ERU can be managed with medication, but it may eventually lead to blindness in some cases. Our comprehensive ProPanel DNA testing package includes two tests that determine whether your Appaloosa is genetically predisposed to a higher risk of developing ERU (Equine Recurrent Uveitis Risk - ERUR) and if they face an increased risk of ERU symptom severity (Equine Recurrent Uveitis Severity - ERUS). Like EMS, these genetic risk tests cannot determine whether your horse has or will certainly develop ERU, but rather let you know that your horse is at a higher risk of developing ERU and/or developing more severe ERU symptoms.

Do you have an Appaloosa that you would love to learn more about down to their DNA? Check out our Health Panel test which evaluates your horse for all of these health conditions, risk factors, and so much more to get peace of mind today!

Get to know your Appaloosa down to their DNA today!

News & Media

Genetic Health Risks: Chronic Idiopathic Anhidrosis

September 6, 2024

Learn about Chronic Idiopathic Anhidrosis (CIA) in horses, a condition that affects their ability to sweat. Understand genetic risk factors, symptoms, and management strategies with insights from Etalon Equine Genetics.

Etalon's Research

August 7, 2024

Discover Etalon Equine Genetics' groundbreaking DNA studies on horses. Explore past and ongoing research that is transforming equine genetics, improving health, and enhancing performance. Find out how your horse's DNA can make a difference!

Genetic Health Testing for Stock Horses

June 20, 2024

Discover the genetic health conditions most commonly found in Stock Horse breeds including HYPP and Lethal White Overo. Learn how DNA testing with Etalon can improve your stock horse's quality of life today and in the future!

Podcast Episodes

Breeding Backed By Science: Alison Umberger

Genetics Unbridled Podcast | Ep. 7

From a fifth-grade paper to the forefront of equine genetics, Alison Umberger's story is one you won’t want to miss. Dive into the genetic tapestry of...

Press Releases

Etalon Equine Genetics Discovers Three New White Marking Variants in a New Gene

March 19, 2024

Menlo Park, CA - Etalon Equine Genetics has made another landmark discovery in the field of equine genetics. For the first time in 10 years, a new genetic region for color has been found!

Read More

Etalon Equine Genetics Discovers New Novel White Variant in Pura Raza Española Horses

December 23, 2023

Menlo Park, CA - Etalon Equine Genetics, a leading provider of equine DNA testing services, has made an exciting breakthrough in equine genetics.

Read More

APHA Approves New White Marking Variant W35 “Holiday” in Horses Discovered by Etalon Equine Genetics

December 23, 2023

Menlo Park, CA - Etalon Equine Genetics, a leading provider of DNA testing services, has made another novel discovery in the field of equine genetics. The company has identified a new white marking variant now designated as W35.

Read More